“Other Drugs”: Exploring the Rest of AOD
-
You must log in to register
- Non-member - $179
- Member - $79
We group all drugs in the phrase “AOD”, but we give most of our attention to alcohol and cannabis. We are right to: alcohol and cannabis are widely used. Yet now is an important moment to focus on “Other Drugs”, including cocaine, psychedelics, and ketamine. These drugs are on our campuses and finding an increasingly accepted place in our culture. From the dark web to decriminalization, join us on this webinar to get an update on "Other Drugs" and discuss how we may better address this topic with students.
Featuring
- Tom Fontana, University of Vermont
Learning Outcomes
- Learn about trends and culture around “other drugs”, including: psychedelics, ketamine, cocaine, rx simulants, MDMA, benzos
- Consider ways to engage, support and educate students about these substances, including harm reduction strategies and overdose prevention
- Discuss ways to adapt this work to each campus, given varying campus cultures, student populations, and administrative support
Tom Fontana, LCMHC, LADC
Alcohol, Cannabis & Other Drugs Initiatives Manager
The University of Vermont
Tom Fontana (he/him) is the Alcohol, Cannabis, and Other Drugs Initiatives Manager for the University of Vermont. He coordinates prevention, education, and the brief intervention model, BASICS, which is designed to assist students in exploring their relationship with substance use in a shame-free environment. This provides the opportunity to talk with hundreds of students each year individually. Additionally, Tom meets with student groups, including FSL and Athletics. Tom is lucky to be part of an Alcohol, Cannabis and Other Drugs Team (ACOD), whose goal is education and transformation. (Education is for individuals, to support non-use and safe-use; Transformation is for groups and culture, to disrupt harm and misuse.) When these aspects come together, meaningful change is possible.
Key:
Complete
Next
Failed
Available
Locked
